【结 构 式】 |
【分子编号】49022 【品名】 【CA登记号】 |
【 分 子 式 】C11H13FO3S2 【 分 子 量 】276.3528232 【元素组成】C 47.81% H 4.74% F 6.87% O 17.37% S 23.21% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(-)-(XVI)Alternatively, intermediate (1R,2S,5R,6S)-(XIX) can also be obtained by first separation of the isomeric mixture (±)-(X) by chiral HPLC to provide isomer (+)-(X), which is then subjected to the same process described for (±)-(X) in Scheme 28677701a to furnish the desired compound (1R,2S,5R,6S)-(XIX).
【2】 Kumagai, T.; Sakagami, K.; Nakazato, A.; Tomisawa, K. (Taisho Pharmaceutical Co., Ltd.); 6-Fluorobicyclo[3.1.0]hexane derivs.. EP 1110943; JP 2000336071; WO 0012464 . |
【1】 Nakazato, A.; et al.; Synthesis, SAR, and biological activities of potent and selective group II mGluR agonists, novel 2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 104. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(rac)-(X) | 49005 | ethyl (rac)-(1S*,5S*,6S*)-6-fluoro-2-oxobicyclo[3.1.0]hexane-6-carboxylate | C9H11FO3 | 详情 | 详情 | |
(+)-(X) | 49017 | ethyl (+)-(1S,5S,6S)-6-fluoro-2-oxobicyclo[3.1.0]hexane-6-carboxylate | C9H11FO3 | 详情 | 详情 | |
(+)-(XI) | 49018 | ethyl (+)-(1S,5S,6S)-6-fluoro-4-oxobicyclo[3.1.0]hex-2-ene-6-carboxylate | C9H9FO3 | 详情 | 详情 | |
(-)-(XII) | 49019 | ethyl (-)-(1R,2S,4S,6S,7S)-7-fluoro-5-oxo-3-oxatricyclo[4.1.0.0(2,4)]heptane-7-carboxylate | C9H9FO4 | 详情 | 详情 | |
(-)-(XIII) | 49020 | ethyl (-)-(1R,2R,5S,6S)-6-fluoro-2-hydroxy-4-oxobicyclo[3.1.0]hexane-6-carboxylate | C9H11FO4 | 详情 | 详情 | |
(-)-(XV) | 49021 | C11H15FO3S2 | 详情 | 详情 | ||
(-)-(XVI) | 49022 | C11H13FO3S2 | 详情 | 详情 | ||
(R,S,R,S)(XVII) | 49023 | C11H11FN2O4S2 | 详情 | 详情 | ||
(XIV) | 27313 | 1,2-ethanedithiol | 540-63-6 | C2H6S2 | 详情 | 详情 |
(XVIII) | 10039 | (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine | 3886-69-9 | C8H11N | 详情 | 详情 |
(XIX) | 49012 | C19H20FN3O3S2 | 详情 | 详情 |
Extended Information